Author Interviews, Biomarkers, Diabetes, Diabetes Care, Johns Hopkins / 26.03.2020
Biomarker hsTroponin Predictive of Mortality Risk in Older Diabetics
MedicalResearch.com Interview with:
[caption id="attachment_53641" align="alignleft" width="150"]
Olive Tang[/caption]
Olive Tang, MD/PhD Student
Johns Hopkins School of Medicine
[caption id="attachment_53642" align="alignleft" width="150"]
Dr. Selvin[/caption]
Elizabeth Selvin, PhD, MPH
Professor of Epidemiology & Medicine
Director, Cardiovascular and Clinical Epidemiology
Department of Epidemiology
Welch Center for Prevention, Epidemiology and Clinical Research and the
Johns Hopkins Bloomberg School of Public Health
MedicalResearch.com: What is the background for this study?
Response: The best approach to diabetes management in older adults is unclear. A new blood test called high-sensitivity troponin can detect damage to the heart, even in people without any signs or symptoms of heart disease.
Olive Tang[/caption]
Olive Tang, MD/PhD Student
Johns Hopkins School of Medicine
[caption id="attachment_53642" align="alignleft" width="150"]
Dr. Selvin[/caption]
Elizabeth Selvin, PhD, MPH
Professor of Epidemiology & Medicine
Director, Cardiovascular and Clinical Epidemiology
Department of Epidemiology
Welch Center for Prevention, Epidemiology and Clinical Research and the
Johns Hopkins Bloomberg School of Public Health
MedicalResearch.com: What is the background for this study?
Response: The best approach to diabetes management in older adults is unclear. A new blood test called high-sensitivity troponin can detect damage to the heart, even in people without any signs or symptoms of heart disease.


Dr. Rowan[/caption]
MedicalResearch.com Interview with:
Dr. Janet Rowan
Obstetric Physician
National Women's Health,
Auckland
Medical Research: What is the background for this study?
Dr. Rowan: Clinicians are interested in screening during early pregnancy to identify women with previously unrecognised diabetes, as these women have increased risks of adverse pregnancy outcomes. HbA1c is a simple and reproducible measure of glucose elevations, but its usefulness as an early pregnancy screening test is not clear. The aim of this study was to examine whether pregnant women with an HbA1c of 41-49mmol/mol (5.9-6.6%) are a high risk subgroup and whether treating these women from early pregnancy improves outcomes compared with identifying them during routine screening for gestational diabetes (GDM) from 24 weeks’ gestation.
This observational study compared women referred to the diabetes clinic <24 weeks’ who had an early pregnancy 














